Dr. Cora N. Sternberg of the San Camillo and Forlanini Hospitals in Rome and study coordinator of EORTC trial 30994, presented the long term results of that trial at ASCO 2014 in Chicago. The results lend new support to use of immediate cisplatin-based chemotherapy following surgical resection. An overview of the trial results were reported in the 03 June 2014 ASCO Daily News.
Preliminary results confirm that the addition of bone-protecting agents to Radium-233 (Ra-233) treatment can limit fractures in metastatic castration resistant prostate cancer patients
31 May 2019
23 Nov 2017
17 Nov 2017